Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Prime Medicine, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Investor presentation, Quarterly results
Docs: "Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates",
"Prime Medicine August 2023"
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/12/2023 144 Form 144 - Report of proposed sale of securities:
06/05/2023 144 Form 144 - Report of proposed sale of securities:
05/30/2023 144 Form 144 - Report of proposed sale of securities:
05/18/2023 144 Form 144 - Report of proposed sale of securities:
05/17/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting Data demonstrated Prime Editors efficiently, reproducibly and durably corrected the causative mutation of CGD, supporting advancement of development candidate PM359"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/11/2023 8-K Appointed a new director
05/11/2023 8-K Quarterly results
Docs: "Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates"
05/08/2023 144 Form 144 - Report of proposed sale of securities:
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/10/2023 8-K/A Quarterly results
Docs: "Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
03/09/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/09/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Quarterly results
Docs: "Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update"
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2023 SC 13G/A FMR LLC reports a 8.7% stake in PRIME MEDICINE INC
02/07/2023 SC 13G Newpath Partners, L.P. reports a 5.5% stake in Prime Medicine, Inc.
01/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "FORM 8-K",
"Presentation at 41st Annual J.P. Morgan Healthcare Conference, dated January 2023, furnished herewith",
"Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities"
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/26/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
10/24/2022 8-K Quarterly results
10/21/2022 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
10/20/2022 EFFECT Form EFFECT - Notice of Effectiveness:
10/19/2022 S-1MEF Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
10/19/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
10/19/2022 CERT Form CERT - Certification by an exchange approving securities for listing:
10/17/2022 8-A12B Form 8-A12B - Registration of securities [Section 12(b)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy